Company news
LENZ Therapeutics, Inc. news in 2022
LENZ Therapeutics, Inc.'s news releases, calls and decks from 2022, newest first.
Graphite Bio Presents Preclinical Data for Novel Sequencing Method Used to Determine Gene Editing Outcomes at 64th ASH Annual Meeting
December 10, 2022
Graphite Bio Announces Participation in Evercore ISI 5th Annual HealthCONx Conference
November 20, 2022
Graphite Bio Reports Recent Business Progress and Third Quarter 2022 Financial Results
November 8, 2022
Graphite Bio Announces Abstracts Accepted for Upcoming 64th ASH Annual Meeting and Exposition
November 2, 2022
Graphite Bio Announces Participation in 50th Annual Sickle Cell Disease Association of America National Convention
October 10, 2022
Graphite Bio Announces Participation in Morgan Stanley 20th Annual Global Healthcare Conference
September 5, 2022
Graphite Bio Reports Recent Business Progress and Second Quarter 2022 Financial Results
August 10, 2022
Graphite Bio Doses First Patient with Investigational Gene Editing Therapy GPH101 for Sickle Cell Disease
August 10, 2022
Graphite Bio Announces Participation in Jefferies Healthcare Conference
May 31, 2022
Graphite Bio Reports Recent Business Progress and First Quarter 2022 Financial Results
May 11, 2022
Graphite Bio Announces Participation in Upcoming Investor Conferences
May 3, 2022
Graphite Bio Announces U.S. FDA Fast Track Designation Granted to GPH101 for the Treatment of Sickle Cell Disease
May 2, 2022
Graphite Bio Announces Participation in the ASGCT 25th Annual Meeting Including Oral Presentation About Beta-thalassemia Program
May 1, 2022
Graphite Bio Announces Participation in H.C. Wainwright Gene Therapy and Gene Editing Virtual Conference
March 27, 2022
Graphite Bio Announces Formation of Scientific Advisory Board
March 22, 2022
Graphite Bio Reports Recent Business Progress and Fourth Quarter and Fiscal Year 2021 Financial Results
March 20, 2022
Graphite Bio Announces Participation in Upcoming Cowen 42nd Annual Health Care Conference
March 2, 2022
Graphite Bio Appoints Alethia Young as Chief Financial Officer
March 1, 2022
Decks in 2022
- Technical Presentation (June 2022)
Technical · 16 slides · June 2022
- Investor Presentation (May 2022)
Investor deck · 23 slides · May 2022